Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome
Open Access
- 11 October 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (10), e0223329
- https://doi.org/10.1371/journal.pone.0223329
Abstract
This study aimed to evaluate the clinical manifestations and health risks associated with polycystic ovary syndrome (PCOS) and its impact on quality of life (QOL) in Pakistan. A detailed cross-sectional study was conducted on PCOS among women of reproductive age visiting the gynecology and obstetrics and endocrinology departments at primary and tertiary care hospitals located in Abbottabad, Kohat, and Islamabad. In total, 440 patients meeting the inclusion criteria were included. A checklist was specifically designed to identify symptoms and health risks, including adverse drug reactions, complications, irrational prescription or underprescription, and drug–drug interactions. The Short Form-12 questionnaire was used to evaluate the QOL of patients with PCOS. Data collected were analyzed for descriptive and inferential statistics using chi-square test, analysis of variance, and post hoc analysis. All patients exhibited the cardinal symptoms of PCOS, including obesity (n = 352, 80%), acne (n = 296, 67.3), hirsutism (n = 299, 68%), hyperglycemia (n = 278, 63.2%), and irregular menstruation (n = 316, 71.8%). Ultrasonography confirmed that 268 (61%) patients had multiple cysts of >10 mm in diameter. Patients with untreated PCOS exhibited a high prevalence of health risks including hypertension (n = 87, 19.8%), diabetes (n = 268, 60.9%), sleep apnea (n = 11, 2.5%), infertility (n = 146, 33.2%), increased endometrial thickness (n = 21, 4.8%), miscarriages (n = 68, 15.5%), high cholesterol level (n = 85, 19.3%), and hyperandrogenism (n = 342, 77.7%). Most patients exhibited low QOL scores (n = 374, 85%), with depression being the largest contributor to low QOL. Apart from novel results, this study found an association between depression and low QOL in patients with PCOS, suggesting the need for reviewing the management guidelines and psychological health assessment of women with PCOS.This publication has 41 references indexed in Scilit:
- Longitudinal weight gain in women identified With polycystic ovary syndrome: Results of an observational study in young womenObesity, 2013
- Is the prevalence of overweight and obesity declining among 4‐year‐old Swedish children?Acta Paediatrica, 2009
- Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in GermanyHuman Reproduction, 2009
- Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorderDrug, Healthcare and Patient Safety, 2009
- Polycystic Ovary Syndrome and Endometrial CancerSeminars in Reproductive Medicine, 2008
- Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990Fertility and Sterility, 2007
- Quality of life and psychological well being in polycystic ovary syndromeHuman Reproduction, 2007
- Quality of Life Assessment Using the Short Form-12 (SF-12) Questionnaire in Patients With Cervical Spondylotic MyelopathySpine, 2006
- Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2005
- Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertilityHuman Reproduction, 2004